Holen Sie sich die Stockscreener-App
32.83
1.50%
-0.50
Handel nachbörslich:
32.83
Schlusskurs vom Vortag:
$33.33
Offen:
$33.09
24-Stunden-Volumen:
577.24K
Relative Volume:
0.60
Marktkapitalisierung:
$3.52B
Einnahmen:
-
Nettoeinkommen (Verlust:
$-167.80M
KGV:
-20.11
EPS:
-1.6323
Netto-Cashflow:
$-144.07M
1W Leistung:
+8.42%
1M Leistung:
+18.01%
6M Leistung:
+113.88%
1J Leistung:
+185.23%
1-Tages-Spanne:
$32.56
$34.00
1-Wochen-Bereich:
$30.67
$34.00
52-Wochen-Spanne:
$10.60
$34.00
Edgewise Therapeutics Inc Stock (EWTX) Company Profile
Firmenname
Edgewise Therapeutics Inc
Sektor
Branche
Telefon
720-262-7002
Adresse
1715 38TH ST, BOULDER
Compare EWTX vs VRTX, REGN, ARGX, ALNY, INSM
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
EWTX
Edgewise Therapeutics Inc
|
32.83 | 3.58B | 0 | -167.80M | -144.07M | -1.6323 |
VRTX
Vertex Pharmaceuticals Inc
|
434.30 | 111.45B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
763.04 | 80.54B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
748.25 | 46.32B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
330.34 | 42.29B | 3.71B | 313.75M | 465.38M | 2.2571 |
INSM
Insmed Inc
|
163.81 | 35.01B | 606.42M | -1.28B | -997.58M | -6.403 |
Edgewise Therapeutics Inc Stock (EWTX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-09-25 | Eingeleitet | Goldman | Neutral |
| 2025-07-30 | Eingeleitet | Raymond James | Strong Buy |
| 2025-06-30 | Eingeleitet | H.C. Wainwright | Buy |
| 2025-04-30 | Eingeleitet | Guggenheim | Buy |
| 2025-04-02 | Herabstufung | Scotiabank | Sector Outperform → Sector Perform |
| 2025-03-07 | Eingeleitet | Scotiabank | Sector Outperform |
| 2025-01-22 | Eingeleitet | Stifel | Hold |
| 2024-11-22 | Eingeleitet | Evercore ISI | Outperform |
| 2024-03-07 | Eingeleitet | Piper Sandler | Overweight |
| 2023-05-01 | Eingeleitet | Truist | Buy |
| 2022-08-25 | Herabstufung | Goldman | Neutral → Sell |
| 2022-04-13 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2022-01-28 | Eingeleitet | Goldman | Neutral |
Alle ansehen
Edgewise Therapeutics Inc Aktie (EWTX) Neueste Nachrichten
Edgewise Therapeutics, Inc. (NASDAQ:EWTX) Given Consensus Recommendation of "Moderate Buy" by Analysts - marketbeat.com
Edgewise Therapeutics (EWTX) Valuation After Positive Becker Muscular Dystrophy Extension Data - Sahm
Breakouts Watch: Is Edgewise Therapeutics Inc subject to activist investor interest2026 Action & Free Technical Pattern Based Buy Signals - baoquankhu1.vn
SG Americas Securities LLC Buys 78,842 Shares of Edgewise Therapeutics, Inc. $EWTX - marketbeat.com
Breakout Move: Is Edgewise Therapeutics Inc being accumulated by smart moneyMarket Performance Summary & Daily Technical Forecast Reports - baoquankhu1.vn
Director at Edgewise Therapeutics (EWTX) awarded 339 new shares - stocktitan.net
Edgewise Therapeutics stock hits 52-week high at 33.5 USD By Investing.com - Investing.com Canada
Edgewise Therapeutics, Inc. (EWTX) PT increased to $45 at JPMorgan amid optimism on EDG-7500 pipeline - MSN
Edgewise Therapeutics (NASDAQ:EWTX) CMO Joanne Donovan Sells 28,662 Shares - MarketBeat
Edgewise Therapeutics CMO sells $926,095 in EWTX stock By Investing.com - Investing.com Canada
Edgewise Therapeutics Insider Sold Shares Worth $926,095, According to a Recent SEC Filing - marketscreener.com
[Form 4] Edgewise Therapeutics, Inc. Insider Trading Activity - stocktitan.net
Edgewise Therapeutics (NASDAQ:EWTX) Sets New 52-Week HighHere's What Happened - marketbeat.com
Hedge Fund Bets: Is Edgewise Therapeutics Inc exposed to currency risksQuarterly Market Summary & Stepwise Trade Signal Implementation - baoquankhu1.vn
Edgewise Therapeutics Reports Inducement Grants as Permitted by the Nasdaq Listing Rules - 富途牛牛
Edgewise Therapeutics Reports Inducement Grants as permitted by the Nasdaq Listing Rules - Finansavisen
EWTX PE Ratio & Valuation, Is EWTX Overvalued - Intellectia AI
Edgewise Therapeutics CMO sells $685k in EWTX stock By Investing.com - Investing.com Canada
Edgewise Therapeutics (EWTX) CMO sells 21,338 shares after option exercise - Stock Titan
Fund Flows: Is Edgewise Therapeutics Inc trading at a discount2026 Intraday Action & Accurate Entry and Exit Point Alerts - baoquankhu1.vn
Insider Sell Alert: Joanne Donovan Sells 16,358 Shares of Edgewi - GuruFocus
Insider Sell Alert: Joanne Donovan Sells 16,358 Shares of Edgewise Therapeutics Inc (EWTX) - GuruFocus
Edgewise Therapeutics CMO Donovan sells $506k in EWTX stock By Investing.com - Investing.com Canada
Edgewise Therapeutics (NASDAQ: EWTX) CMO sells 16,358 shares in open market - stocktitan.net
Edgewise Therapeutics, Inc. (EWTX) PT Increased to $45 at JPMorgan Amid Optimism on EDG-7500 Pipeline - Yahoo Finance
EWTX Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
(EWTX) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
EWTX (NASDAQ) Form 144 lists 71,588 shares from options, ESPP, RSUs - stocktitan.net
Aug Analyst Calls: Can Edgewise Therapeutics Inc reach all time highs this year2026 Major Catalysts & Low Risk High Win Rate Stock Picks - baoquankhu1.vn
Edgewise Therapeutics stock reaches 52-week high at $31.86 By Investing.com - Investing.com Australia
Edgewise Therapeutics (NASDAQ:EWTX) Reaches New 12-Month HighHere's Why - MarketBeat
Edgewise Therapeutics stock reaches 52-week high at $31.86 - Investing.com
Why Edgewise Therapeutics Stock Topped the Market on Tuesday - AOL.com
A Look At Edgewise Therapeutics (EWTX) Valuation After Promising Sevasemten Becker Muscular Dystrophy Data - Sahm
EWTX SEC FilingsEdgewise Therapeutics, Inc. 10-K, 10-Q, 8-K Forms - stocktitan.net
Edgewise Therapeutics team to attend 2026 American College of Cardiology annual meeting - Traders Union
Trading Recap: Can Edgewise Therapeutics Inc keep up with sector leaders2026 Price Targets & Free Community Supported Trade Ideas - baoquankhu1.vn
Why Edgewise Therapeutics stock topped the market on Tuesday - MSN
Inflation Data: What analysts say about Edgewise Therapeutics Inc stock2026 Spike Watch & Stepwise Swing Trade Plans - baoquankhu1.vn
How (EWTX) Movements Inform Risk Allocation Models - Stock Traders Daily
Death Cross: Is Edgewise Therapeutics Inc being accumulated by smart money2026 Action & Verified Short-Term Plans - baoquankhu1.vn
Edgewise Therapeutics Inc (EWTX) Stock Price, Quote, News & History - Benzinga
Why Edgewise Therapeutics Stock Topped the Market on Tuesday - The Motley Fool
JPMorgan Chase & Co. Raises Edgewise Therapeutics (NASDAQ:EWTX) Price Target to $45.00 - MarketBeat
JPMorgan raises Edgewise Therapeutics price target on pipeline outlook By Investing.com - Investing.com Canada
Edgewise Therapeutics' (EWTX) "Outperform" Rating Reiterated at Wedbush - MarketBeat
Is Edgewise Therapeutics Inc being accumulated by smart money2026 Action & Verified Short-Term Plans - baoquankhu1.vn
The $3B Biotech With Two Shots On Goal - Benzinga
Assessing Edgewise Therapeutics (EWTX) Valuation After Encouraging Long Term MESA Study Results - Yahoo Finance
Granahan Investment Management Trims Edgewise Therapeutics Holdings - National Today
HighVista Strategies Boosts Edgewise Therapeutics Stake - National Today
Finanzdaten der Edgewise Therapeutics Inc-Aktie (EWTX)
Umsatz
Nettogewinn
Free Cashflow
ENV
Edgewise Therapeutics Inc-Aktie (EWTX) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Donovan Joanne M. | CMO |
Apr 01 '26 |
Sale |
32.31 |
28,662 |
926,095 |
9,597 |
| Donovan Joanne M. | CMO |
Mar 31 '26 |
Option Exercise |
7.08 |
21,338 |
151,073 |
30,935 |
| Donovan Joanne M. | CMO |
Mar 31 '26 |
Sale |
32.12 |
21,338 |
685,308 |
9,597 |
| Donovan Joanne M. | CMO |
Mar 27 '26 |
Sale |
30.98 |
16,358 |
506,735 |
9,597 |
0.87%
0.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):